Actuate Therapeutics, Inc.Actuate Therapeutics, Inc.Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc.

No trades
See on Supercharts

Price target

25.000.000.00%
The 4 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


In the next quarter Actuate Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Actuate Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ACTU price target is 25.00 USD with a max estimate of 35.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile watch Actuate Therapeutics, Inc. stock price chart and keep track of the current situation with ACTU news and stock market news.